Clinical Trial treatments

for prostate cancer



Clinical Trial treatments for prostate cancer


Clinical Trial Treatments

for Prostate Cancer

A new investigational method for the treatment of localized prostate cancer is currently available in two clinical trials. If you suffer from localized prostate cancer, there is a possibility to take part of the Q-Pro clinical trials and contribute to developing future cancer treatments.

A New Focal Approach to
Prostate Cancer Treatment

Prostate Cancer Treatment
The Q-Pro clinical trials evaluate a new focal treatment option for localised prostate cancer. The intervention is a focal and minimally invasive procedure. This means that the treatment targets only the tumour. The treatment is based on photodynamic therapy (PDT). The goal is to destroy the cancer cells while sparing surrounding healthy tissue. PDT is an approved treatment for some cancers that develop on the surface of the body, like skin cancer. The ambition is to provide an individualised treatment option that eliminates cancer from the prostate and minimises the side effects. 

What you need to know
about the Q-Pro Clinical Trials

The Q-Pro clinical trials include one clinic visit for the study procedure. The procedure is performed during general anesthesia, and it begins with an injection of a drug that makes the tissue sensitive to light. Once a sufficient dose has reached the tumour, laser light is applied inside the prostate to activate the drug. Study participants may be going home the same day or stay in the hospital overnight. After the study procedure, participants will return to the clinic during the following year for study visits to check on their condition and monitor any side effects. 

The drug used in the clinical trials is approved for treating eye diseases. The medical device used to deliver the treatment light individualises the therapy for each patient to optimise the destruction of cancer cells and reduce side effects. 

See If You Are Eligible

Prostate Cancer Clinical Trial Eligibility
Prostate Cancer Clinical Trial Eligibility

If you're eligible, contact the clinic running the study. See contact details below.

Where is the Q-Pro Clinical Trial Taking Place?

Memorial Sloan Kettering Cancer Center in New York City

Contact: 646-422-4894

The study on recurrent prostate cancer is taking place at:


  • Princess Margaret Cancer Centre in Toronto in Canada
  • University College London Hospital in United Kingdom
  • Memorial Sloan Kettering Cancer Center in New York in US
  • Skåne University Hospital in Malmö in Sweden

Watch our videos to learn more about the two trials.

Frequently Asked Questions

  • What is a clinical trial?

    Clinical trials are research studies in which people volunteer to help find answers to specific health questions. When carefully conducted, they are the safest and fastest way to find new treatments and ways to improve health. 


    Volunteers who participate in the study must agree to the rules and terms of the study. Similarly, researchers, doctors, and other health professionals who manage clinical trials must follow strict rules set by the U.S. Food and Drug Administration, FDA. These rules make sure that those who agree to participate are treated as safely as possible.

  • Who is conducting the trial?

    SpectraCure is the sponsor of the clinical trial and the manufacturer of the medical device used for the study procedure. The company has its roots in research at Lund University in Sweden, and the technology is based on long scientific research and clinical treatments using PDT. 


    SpectraCure is sponsoring the clinical trial to evaluate the performance of the medical device. The clinical trial is conducted at several leading prostate cancer clinics in North America and Europe.

  • What are the primary goals of the study?

    The aim of the Q-Pro clinical trial is to investigate the effect and safety of the study procedure using the medical device in combination with the drug Verteporfin for the treatment of recurrent prostate cancer. 

  • What other treatment alternatives are available?

    Men with localized recurrent prostate cancer who are not in a research study are usually treated by reducing their level of male hormones to prevent their cancer from growing. 


    Other treatments for both primary and recurrent localized prostate cancer may include surgical removal of the prostate, or treatments that either heat or freeze the prostate tissue to destroy the tumor. 


    However, the treatment of recurrent prostate cancer after radiotherapy is controversial due to the serious side effects associated with several methods.

  • What is focal treatment?

    Focal treatment for prostate cancer involves targeting and treating only the specific area of the prostate where cancer is detected, rather than treating the entire prostate. This approach aims to minimize side effects by preserving healthy tissue surrounding the cancerous area. 

Share by: